Jane Street Group, LLC Nrx Pharmaceuticals, Inc. Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.29 - $0.7 $8,028 - $19,379	27,685 New	27,685 $13,000
Q2 2023 Aug 14, 2023	BUY	$0.46 - $0.89 $6,923 - $13,396	15,052 New	15,052 $7,000
Q1 2022 May 17, 2022	SELL	$2.45 - $5.04 $131,643 - $270,809	-53,732 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$4.5 - $11.91 $104,850 - $277,503	-23,300 Reduced 30.25%	53,732 $257,000
Q3 2021 Nov 16, 2021	BUY	$8.52 - $24.77 $656,312 - $1.91 Million	77,032 New	77,032 $714,000

17.4K

Ticker NRXP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,641,296
Market Cap $81.2M
Description
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-10...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.